New study probes BGF 160's effect on COPD breathing patterns
NCT ID NCT06110403
First seen Jan 10, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study looks at how the inhaled medication BGF 160 changes the way people with stable COPD breathe. Researchers will measure breathing complexity and lung function in 35 adults aged 40-75. The goal is to understand how the drug works, not to test if it cures or controls the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Lille
RECRUITINGLille, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.